OMCL
Omnicell, Inc.

728
Mkt Cap
$2.41B
Volume
463,358.00
52W High
$47.69
52W Low
$22.66
PE Ratio
103.12
OMCL Fundamentals
Price
$43.29
Prev Close
$43.97
Open
$44.09
50D MA
$34.13
Beta
0.90
Avg. Volume
405,430.16
EPS (Annual)
$0.2709
P/B
1.62
Rev/Employee
$303,062.13
Loading...
Loading...
News
all
press releases
Omnicell (NASDAQ:OMCL) Downgraded to Hold Rating by Zacks Research
Zacks Research cut Omnicell from a "strong-buy" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Is it Worth Retaining NEOG Stock in Your Portfolio for Now?
Neogen leans on new product launches and 3M Food Safety integration to offset solvency strains and macro pressures.
Zacks·1d ago
News Placeholder
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?
PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.
Zacks·1d ago
News Placeholder
WINTON GROUP Ltd Makes New Investment in Omnicell, Inc. $OMCL
WINTON GROUP Ltd purchased a new stake in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
Omnicell (NASDAQ:OMCL) Given New $50.00 Price Target at Benchmark
Benchmark increased their price objective on Omnicell from $45.00 to $50.00 and gave the stock a "buy" rating in a research note on Tuesday...
MarketBeat·2d ago
News Placeholder
ALGN Stock Rises on Thailand Launch of Invisalign With MAOB
Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.
Zacks·2d ago
News Placeholder
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance.
Zacks·2d ago
News Placeholder
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
Zacks·2d ago
News Placeholder
American Century Companies Inc. Has $3.38 Million Holdings in Omnicell, Inc. $OMCL
American Century Companies Inc. reduced its holdings in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 37.7% in the 2nd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, today announced the launch of Omnicell Titan XT, a transformational...
Business Wire·3d ago

Latest OMCL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.